IGRAs--the gateway to T cell based TB diagnosis (Q43466707)

23 November 2017

IGRAs--the gateway to T cell based TB diagnosis (English)

1 reference

23 November 2017

Hilary S Whitworth

1

0 references

Ajit Lalvani

object named as

Ajit Lalvani

5

0 references

author name string

Melanie Scott

2

1 reference

23 November 2017

David W Connell

3

1 reference

23 November 2017

Bianca Dongés

4

1 reference

23 November 2017

4 January 2013

1 reference

23 November 2017

1 reference

23 November 2017

61

1 reference

23 November 2017

52-62

1 reference

23 November 2017

1

1 reference

Mechanisms of latency in Mycobacterium tuberculosis

23 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Persistent and dormant tubercle bacilli and latent tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Tuberculosis in the UK--time to regain control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Mantoux Test as a model for a secondary immune response in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

The tuberculin skin test is unreliable in school children BCG-vaccinated in infancy and at low risk of tuberculosis infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contacts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

T cells in mycobacterial infection and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Cell-mediated immune responses in tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Early T-cell responses in tuberculosis immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Development of a simple, rapid in vitro cellular assay for bovine tuberculosis based on the production of gamma interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Field comparison of the interferon-gamma assay and the intradermal tuberculin test for the diagnosis of bovine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

BOVIGAM: an in vitro cellular diagnostic test for bovine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Comparison of a whole-blood interferon-γ assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Interferon gamma assays for tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Interferon- release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Risk for tuberculosis among children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Identifying recent Mycobacterium tuberculosis transmission in the setting of high HIV and TB burden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Screening for tuberculosis infection prior to initiation of anti-TNF therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Assessment of cross-reactivity between Mycobacterium bovis and M. kansasii ESAT-6 and CFP-10 at the T-cell epitope level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

A 100 year update on diagnosis of tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

The spectrum of latent tuberculosis: rethinking the biology and intervention strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Frequencies of region of difference 1 antigen-specific but not purified protein derivative-specific gamma interferon-secreting T cells correlate with the presence of tuberculosis disease but do not distinguish recent from remote latent infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Improved diagnostic evaluation of suspected tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Serial T-SPOT.TB and quantiFERON-TB-Gold In-Tube assays to monitor response to antitubercular treatment in Italian children with active or latent tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Utility of interferon-γ release assay results to monitor anti-tubercular treatment in adults and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

T Cells and Tuberculosis: Beyond Interferon‐γ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Polyfunctional T cells in human tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Mycobacterium tuberculosis-specific cellular immune profiles suggest bacillary persistence decades after spontaneous cure in untreated tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.12.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMETH.2012.12.012

1 reference

release_3msikyjenzdvbifjdgpyfhk7iy

23 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3msikyjenzdvbifjdgpyfhk7iy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference